- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison between liposomal formulations of amphotericin B
Authors
Keywords
-
Journal
MEDICAL MYCOLOGY
Volume 54, Issue 3, Pages 223-231
Publisher
Oxford University Press (OUP)
Online
2016-01-15
DOI
10.1093/mmy/myv111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-Dose Indigenous Liposomal Amphotericin B in the Treatment of Indian Visceral Leishmaniasis: A Phase 2 Study
- (2015) Shyam Sundar et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice
- (2014) J. A. Olson et al. MEDICAL MYCOLOGY
- Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India
- (2014) Sakib Burza et al. PLoS Neglected Tropical Diseases
- Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study
- (2014) Shyam Sundar et al. PLoS Neglected Tropical Diseases
- Different liposomal amphotericin B formulations for visceral leishmaniasis
- (2014) Thomas P C Dorlo et al. Lancet Global Health
- Diagnosis and Treatment of Invasive Fungal Infections Focus on Liposomal Amphotericin B
- (2013) João F. Lacerda et al. CLINICAL DRUG INVESTIGATION
- Efficacy and Quality of Antibacterial Generic Products Approved for Human Use: A Systematic Review
- (2013) P. Tattevin et al. CLINICAL INFECTIOUS DISEASES
- Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B
- (2013) Angela S Loo et al. Expert Opinion On Drug Safety
- Liposomal amphotericin B as a treatment for human leishmaniasis
- (2012) Manica Balasegaram et al. EXPERT OPINION ON EMERGING DRUGS
- A randomized comparative trial evaluating the safety and efficacy of liposomal amphotericin B (FungisomeTM) versus conventional amphotericin B in the empirical treatment of febrile neutropenia in India
- (2012) MP Jadhav et al. INDIAN JOURNAL OF CANCER
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
- (2012) Ana C. Mesa-Arango et al. Frontiers in Microbiology
- Formulation and evaluation of long circulating liposomal Amphotericin B: A scinti-kinetic study using99mTc in BALB/C mice
- (2011) MP Jadhav et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS‐Associated Acute Cryptococcal Meningitis: A Randomized, Double‐Blind Clinical Trial of Efficacy and Safety
- (2010) Richard J. Hamill et al. CLINICAL INFECTIOUS DISEASES
- Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
- (2010) Shyam Sundar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liposomal Amphotericin B
- (2009) Marit D. Moen et al. DRUGS
- Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing
- (2008) C. Lass-Florl et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More